Sam Kay

Sam Kay is an experienced professional in the pharmaceutical and regulatory sectors, currently serving as Vice President of Pharma at Basil Systems since February 2024, where efforts focus on leveraging AI and Machine Learning for data-driven decision-making. Prior roles include Principal Regulatory Consultant at Clarivate, Regulatory Intelligence Lead at Gilead Sciences, and Regulatory Affairs Consultant at Key Pharmaceuticals Limited, where responsibilities encompassed regulatory intelligence, quality assurance, and pharmacovigilance. Sam Kay also has a background in financial consulting from Edward Bond Wealth Management. Educational credentials include a Master’s Degree in Pharmacy from Kingston University and various financial planning certifications.